{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:10489"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:10489","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Investigation of T cell responses in multiple sclerosis","abstract":"Multiple myelin proteins, including myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and myelin proteolipid protein (PLP), are critical T cell autoantigens in multiple sclerosis (MS). However, the contribution of these autoreactive T cells to disease pathology remains unknown. We identified CCR6+ CD4+ myelin-reactive T cells in the peripheral blood of healthy controls where they produced low levels of inflammatory and regulatory cytokines. CCR6+ myelin reactive T cells from patients with untreated MS exhibited significantly enhanced production of interferon-γ (IFN-γ), interleukin-17 (IL-17), granulocytemacrophage colony- stimulating factor (GM-CSF) and Tumor necrosis factor-α (TNFα) compared to healthy controls. However, IL-10 expression was less abundant in healthy controls when compared to untreated MS patients, suggesting a role for IL-10 in regulating the pathology of MS when there is inflammation. Interestingly, the proinflammatory profile of CCR6+ myelin reactive T cells including GM-CSF, IFN-γ, IL17 and TNF-α were higher in MS patients treated with IFN-β. Our data suggest that despite the impact of IFN-β on reducing relapse rates in MS, there is little impact on the frequency of pro-inflammatory cytokine secreting autoantigenspecific CCR6+ CD4+ T cells. It remains to be established if the increased proinflammatory cytokine production is present early during the disease.","abstract_html":"Multiple myelin proteins, including myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and myelin proteolipid protein (PLP), are critical T cell autoantigens in multiple sclerosis (MS). However, the contribution of these autoreactive T cells to disease pathology remains unknown. We identified CCR6+ CD4+ myelin-reactive T cells in the peripheral blood of healthy controls where they produced low levels of inflammatory and regulatory cytokines. CCR6+ myelin reactive T cells from patients with untreated MS exhibited significantly enhanced production of interferon-γ (IFN-γ), interleukin-17 (IL-17), granulocytemacrophage colony- stimulating factor (GM-CSF) and Tumor necrosis factor-α (TNFα) compared to healthy controls. However, IL-10 expression was less abundant in healthy controls when compared to untreated MS patients, suggesting a role for IL-10 in regulating the pathology of MS when there is inflammation. Interestingly, the proinflammatory profile of CCR6+ myelin reactive T cells including GM-CSF, IFN-γ, IL17 and TNF-α were higher in MS patients treated with IFN-β. Our data suggest that despite the impact of IFN-β on reducing relapse rates in MS, there is little impact on the frequency of pro-inflammatory cytokine secreting autoantigenspecific CCR6+ CD4+ T cells. It remains to be established if the increased proinflammatory cytokine production is present early during the disease.","abstract_has_math":false,"creators":["Al Mulhim, Muneera"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-07","date_published":"2020-07","updated_at":"2026-11-19T09:31:08Z","subjects":["Q Science (General)","QH426 Genetics","QR180 Immunology","R Medicine (General)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/10489/9/AlMulhim20PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A10489","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Al Mulhim, Muneera"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-07-11"]},{"key":"dc:date.issued","label":"Date","values":["2020-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/10489/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Q Science (General)","QH426 Genetics","QR180 Immunology","R Medicine (General)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/10489/9/AlMulhim20PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Multiple myelin proteins, including myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and myelin proteolipid protein (PLP), are critical T cell autoantigens in multiple sclerosis (MS). However, the contribution of these autoreactive T cells to disease pathology remains unknown. We identified CCR6+ CD4+ myelin-reactive T cells in the peripheral blood of healthy controls where they produced low levels of inflammatory and regulatory cytokines. CCR6+ myelin reactive T cells from patients with untreated MS exhibited significantly enhanced production of interferon-γ (IFN-γ), interleukin-17 (IL-17), granulocytemacrophage colony- stimulating factor (GM-CSF) and Tumor necrosis factor-α (TNFα) compared to healthy controls. However, IL-10 expression was less abundant in healthy controls when compared to untreated MS patients, suggesting a role for IL-10 in regulating the pathology of MS when there is inflammation. Interestingly, the proinflammatory profile of CCR6+ myelin reactive T cells including GM-CSF, IFN-γ, IL17 and TNF-α were higher in MS patients treated with IFN-β. Our data suggest that despite the impact of IFN-β on reducing relapse rates in MS, there is little impact on the frequency of pro-inflammatory cytokine secreting autoantigenspecific CCR6+ CD4+ T cells. It remains to be established if the increased proinflammatory cytokine production is present early during the disease."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Investigation of T cell responses in multiple sclerosis"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Al Mulhim, Muneera"],"dc:date":["2020-07-11"],"dc:date.issued":["2020-07"],"dc:description.abstract":["Multiple myelin proteins, including myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and myelin proteolipid protein (PLP), are critical T cell autoantigens in multiple sclerosis (MS). However, the contribution of these autoreactive T cells to disease pathology remains unknown. We identified CCR6+ CD4+ myelin-reactive T cells in the peripheral blood of healthy controls where they produced low levels of inflammatory and regulatory cytokines. CCR6+ myelin reactive T cells from patients with untreated MS exhibited significantly enhanced production of interferon-γ (IFN-γ), interleukin-17 (IL-17), granulocytemacrophage colony- stimulating factor (GM-CSF) and Tumor necrosis factor-α (TNFα) compared to healthy controls. However, IL-10 expression was less abundant in healthy controls when compared to untreated MS patients, suggesting a role for IL-10 in regulating the pathology of MS when there is inflammation. Interestingly, the proinflammatory profile of CCR6+ myelin reactive T cells including GM-CSF, IFN-γ, IL17 and TNF-α were higher in MS patients treated with IFN-β. Our data suggest that despite the impact of IFN-β on reducing relapse rates in MS, there is little impact on the frequency of pro-inflammatory cytokine secreting autoantigenspecific CCR6+ CD4+ T cells. It remains to be established if the increased proinflammatory cytokine production is present early during the disease."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/10489/9/AlMulhim20PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/10489/"],"dc:subject":["Q Science (General)","QH426 Genetics","QR180 Immunology","R Medicine (General)"],"dcterms:accessrights":["public"],"dc:title":["Investigation of T cell responses in multiple sclerosis"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:31:08Z"}